Cargando…
Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling
BACKGROUND: The aim of this discovery study was the identification of peptide serum biomarkers for detecting biliary tract cancer (BTC) using samples from healthy volunteers and benign cases of biliary disease as control groups. This work was based on the hypothesis that cancer-specific exopeptidase...
Autores principales: | Sandanayake, Neomal S, Camuzeaux, Stephane, Sinclair, John, Blyuss, Oleg, Andreola, Fausto, Chapman, Michael H, Webster, George J, Smith, Ross C, Timms, John F, Pereira, Stephen P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923428/ https://www.ncbi.nlm.nih.gov/pubmed/24495412 http://dx.doi.org/10.1186/1472-6890-14-7 |
Ejemplares similares
-
A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures
por: Sandanayake, N S, et al.
Publicado: (2011) -
Calcineurin inhibitors in steroid and anti‐TNF‐alpha refractory immune checkpoint inhibitor colitis
por: Zhang, Eva, et al.
Publicado: (2021) -
MALDI-MS Imaging of Urushiols in Poison Ivy Stem
por: Aziz, Mina, et al.
Publicado: (2017) -
MALDI-MS Analysis of Peptide Libraries Expands the Scope of Substrates for Farnesyltransferase
por: Schey, Garrett L., et al.
Publicado: (2021) -
Quantitative Measurements of Cell−Cell Signaling Peptides with Single-Cell MALDI MS
por: Rubakhin, Stanislav S., et al.
Publicado: (2008)